CSIMarket
 


Henry Schein Inc   (NASDAQ: HSIC)
Other Ticker:  
 

Henry Schein Inc 's Working Capital Ratio

HSIC's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth

 


In the wake of the increase in Current Liabilities in the first quarter 2025, Working Capital Ratio fell to 1.42 below Henry Schein Inc average.

Within Medical Equipment & Supplies industry 126 other companies have achieved higher Working Capital Ratio than Henry Schein Inc in first quarter 2025. While Working Capital Ratio total ranking has improved so far during the Q1 2025 to 2183, from total ranking in the fourth quarter 2024 at 2719.

Explain Working Capital Ratio
How much Current Assetss HSIC´s has?
What are HSIC´s Current Liabilities?


HSIC Working Capital Ratio (Mar 29 2025)
Q1
(Dec 28 2024)
Q4
(Sep 28 2024)
Q3
(Jun 29 2024)
Q2
(Mar 30 2024)
Q1
Y / Y Current Liabilities Change 25.72 % 4.8 % 41.26 % 12.35 % 7.62 %
Y / Y Current Assets Change -1.01 % -11.25 % 0.83 % 0.77 % 3.19 %
Working Capital Ratio MRQ 1.42 1.46 1.45 1.59 1.81
HSIC's Total Ranking # 2183 # 2719 # 2802 # 2676 # 2483
Seq. Current Liabilities Change 4.11 % -4.35 % 15.28 % 9.52 % -13.22 %
Seq. Current Assets Change 1.36 % -3.95 % 5.23 % -3.36 % -9.14 %



Working Capital Ratio first quarter 2025 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 127
Healthcare Sector # 624
Overall Market # 2183


Working Capital Ratio Statistics
High Average Low
2.04 1.68 1.29
(Sep 30 2023)   (Jun 30 2018)




Financial Statements
Henry Schein Inc 's Current Liabilities $ 2,840 Millions Visit HSIC's Balance sheet
Henry Schein Inc 's Current Assets $ 4,037 Millions Visit HSIC's Balance sheet
Source of HSIC's Sales Visit HSIC's Sales by Geography


Cumulative Henry Schein Inc 's Working Capital Ratio

HSIC's Working Capital Ratio for the trailling 12 Months

HSIC Working Capital Ratio

(Mar 29 2025)
12 Months
(Dec 28 2024)
12 Months
(Sep 28 2024)
12 Months
(Jun 29 2024)
12 Months
(Mar 30 2024)
12 Months
Y / Y Current Liabilities TTM Growth 19.94 % 15.58 % 20.27 % 9.72 % 9.09 %
Y / Y Current Assets TTM Growth -2.91 % -1.91 % 4.32 % 5.14 % 5.76 %
Working Capital Ratio TTM 1.48 1.57 1.63 1.78 1.83
Total Ranking TTM # 2609 # 1300 # 2473 # 2018 # 2396
Seq. Current Liabilities TTM Growth 5.63 % 1.23 % 8.9 % 2.99 % 1.79 %
Seq. Current Assets TTM Growth -0.25 % -3.03 % 0.2 % 0.18 % 0.77 %


On the trailing twelve months basis Due to rise in Current Liabilities in the Q1 2025 to $2,840.00 millions, cumulative Working Capital Ratio decreased to 1.48 below the Henry Schein Inc average Working Capital Ratio.
Working Capital Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 137 other companies have achieved higher Working Capital Ratio than Henry Schein Inc . While Working Capital Ratio total ranking has deteriorated compared to the previous twelve months ending in the fourth quarter 2024 from 1300 to 2609.

Explain Working Capital Ratio
How much Current Assetss HSIC´s has?
What are HSIC´s Current Liabilities?

TTM Working Capital Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 138
Healthcare Sector # 717
Within the Market # 2609


trailing twelve months Working Capital Ratio Statistics
High Average Low
1.84 1.64 1.33
(March 31, 2014)   (Dec 29 2018)




Companies with similar Working Capital Ratio in the quarter ending Mar 29 2025, within Medical Equipment & Supplies Industry Working Capital RatioMar 29 2025 MRQ Current AssetsMar 29 2025 MRQ Current Liabilities
Lakeland Industries Inc   3.88 $ 140.706  Millions$ 36.267  Millions
Icad Inc  3.77 $ 28.122  Millions$ 7.458  Millions
Inogen Inc   3.58 $ 200.708  Millions$ 56.096  Millions
Integer Holdings Corporation  3.55 $ 702.203  Millions$ 197.695  Millions
Cadre Holdings inc   3.55 $ 332.515  Millions$ 93.666  Millions
Clearpoint Neuro Inc   3.53 $ 24.214  Millions$ 6.866  Millions
Orchestra Biomed Holdings Inc   3.48 $ 51.903  Millions$ 14.899  Millions
Resmed Inc   3.41 $ 3,208.420  Millions$ 940.516  Millions
Genedx Holdings Corp   3.40 $ 225.816  Millions$ 66.417  Millions
Establishment Labs Holdings Inc   3.36 $ 231.696  Millions$ 69.038  Millions
West Pharmaceutical Services Inc   3.33 $ 1,457.500  Millions$ 437.100  Millions
Neuronetics Inc   3.05 $ 60.668  Millions$ 19.919  Millions
Lyra Therapeutics Inc   2.96 $ 33.905  Millions$ 11.470  Millions
Msa Safety Inc  2.94 $ 823.162  Millions$ 280.440  Millions
Adagio Medical Holdings inc   2.89 $ 17.373  Millions$ 6.006  Millions
Avanos Medical Inc   2.78 $ 352.400  Millions$ 126.800  Millions
Pro dex Inc   2.73 $ 49.943  Millions$ 18.317  Millions
Bluejay Diagnostics Inc  2.71 $ 3.572  Millions$ 1.317  Millions
Orthofix Medical Inc   2.71 $ 390.310  Millions$ 144.116  Millions
Warby Parker Inc   2.70 $ 330.597  Millions$ 122.613  Millions
Myomo Inc   2.66 $ 31.097  Millions$ 11.675  Millions
Icu Medical Inc  2.59 $ 1,423.915  Millions$ 549.024  Millions
Tandem Diabetes Care Inc   2.59 $ 663.435  Millions$ 256.485  Millions
Carlisle Companies Incorporated  2.58 $ 1,531.600  Millions$ 593.100  Millions
Ufp Technologies Inc   2.58 $ 205.886  Millions$ 79.874  Millions
Enovis Corp  2.55 $ 1,218.181  Millions$ 477.423  Millions
Fractyl Health Inc   2.50 $ 47.045  Millions$ 18.801  Millions
Embecta Corp   2.48 $ 643.400  Millions$ 259.300  Millions
Docgo Inc   2.44 $ 262.531  Millions$ 107.571  Millions
Zimmer Biomet Holdings Inc   2.44 $ 5,590.300  Millions$ 2,294.900  Millions

Date modified: 2025-05-06T07:48:28+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com